2021 Q1 Form 10-Q Financial Statement
#000156459021021144 Filed on April 28, 2021
Income Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| Revenue | $251.4M | $246.2M |
| YoY Change | 2.1% | 10.36% |
| Cost Of Revenue | $41.00M | $47.21M |
| YoY Change | -13.16% | 4.08% |
| Gross Profit | $210.4M | $199.0M |
| YoY Change | 5.72% | 11.97% |
| Gross Profit Margin | 83.69% | 80.83% |
| Selling, General & Admin | $125.2M | $133.4M |
| YoY Change | -6.13% | -5.56% |
| % of Gross Profit | 59.51% | 67.02% |
| Research & Development | $92.30M | $93.28M |
| YoY Change | -1.05% | -9.06% |
| % of Gross Profit | 43.87% | 46.87% |
| Depreciation & Amortization | $19.60M | $20.61M |
| YoY Change | -4.89% | 4.92% |
| % of Gross Profit | 9.32% | 10.36% |
| Operating Expenses | $226.9M | $226.7M |
| YoY Change | 0.11% | -7.03% |
| Operating Profit | -$16.50M | -$37.37M |
| YoY Change | -55.85% | -50.83% |
| Interest Expense | -$1.000M | -$100.0K |
| YoY Change | 900.0% | -102.86% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $900.0K | $6.045M |
| YoY Change | -85.11% | -124.93% |
| Pretax Income | -$18.70M | -$31.33M |
| YoY Change | -40.3% | -68.75% |
| Income Tax | $3.800M | $7.300M |
| % Of Pretax Income | ||
| Net Earnings | -$22.42M | -$38.65M |
| YoY Change | -42.0% | -59.9% |
| Net Earnings / Revenue | -8.92% | -15.7% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$140.4K | -$244.8K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 159.2M | 157.8M |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $541.0M | $496.0M |
| YoY Change | 9.07% | -14.79% |
| Cash & Equivalents | $205.0M | $176.1M |
| Short-Term Investments | $336.0M | $319.9M |
| Other Short-Term Assets | $78.00M | $46.40M |
| YoY Change | 68.1% | -17.88% |
| Inventory | $134.2M | $109.3M |
| Prepaid Expenses | ||
| Receivables | $252.8M | $260.9M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $1.006B | $912.6M |
| YoY Change | 10.23% | -5.2% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $346.3M | $362.5M |
| YoY Change | -4.47% | 13.29% |
| Goodwill | $92.87M | $92.87M |
| YoY Change | 0.0% | 0.0% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $86.40M | $53.70M |
| YoY Change | 60.89% | 10.49% |
| Other Assets | $117.3M | $148.7M |
| YoY Change | -21.12% | 11.55% |
| Total Long-Term Assets | $872.2M | $913.3M |
| YoY Change | -4.5% | 15.05% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $1.006B | $912.6M |
| Total Long-Term Assets | $872.2M | $913.3M |
| Total Assets | $1.878B | $1.826B |
| YoY Change | 2.86% | 3.95% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $36.10M | $43.18M |
| YoY Change | -16.4% | -11.8% |
| Accrued Expenses | $318.8M | $287.0M |
| YoY Change | 11.08% | 4.82% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $3.000M | $2.800M |
| YoY Change | 7.14% | -1.51% |
| Total Short-Term Liabilities | $365.8M | $339.8M |
| YoY Change | 7.65% | 3.7% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $294.7M | $273.8M |
| YoY Change | 7.63% | -0.77% |
| Other Long-Term Liabilities | $166.5M | $149.3M |
| YoY Change | 11.52% | 425.24% |
| Total Long-Term Liabilities | $461.2M | $423.1M |
| YoY Change | 9.0% | 39.02% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $365.8M | $339.8M |
| Total Long-Term Liabilities | $461.2M | $423.1M |
| Total Liabilities | $827.1M | $762.9M |
| YoY Change | 8.42% | 16.58% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $1.051B | $1.063B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $1.878B | $1.826B |
| YoY Change | 2.86% | 3.95% |
Cashflow Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$22.42M | -$38.65M |
| YoY Change | -42.0% | -59.9% |
| Depreciation, Depletion And Amortization | $19.60M | $20.61M |
| YoY Change | -4.89% | 4.92% |
| Cash From Operating Activities | -$45.15M | -$40.27M |
| YoY Change | 12.1% | -281.31% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $7.986M | $19.80M |
| YoY Change | -59.66% | -16.24% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$29.70M | $37.30M |
| YoY Change | -179.62% | -190.75% |
| Cash From Investing Activities | -$37.73M | $17.49M |
| YoY Change | -315.71% | -127.03% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | $711.0K | |
| YoY Change | 0.0% | |
| Cash From Financing Activities | 14.95M | -4.924M |
| YoY Change | -403.51% | -611.32% |
| NET CHANGE | ||
| Cash From Operating Activities | -45.15M | -40.27M |
| Cash From Investing Activities | -37.73M | 17.49M |
| Cash From Financing Activities | 14.95M | -4.924M |
| Net Change In Cash | -67.93M | -27.70M |
| YoY Change | 145.21% | -33.29% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$45.15M | -$40.27M |
| Capital Expenditures | $7.986M | $19.80M |
| Free Cash Flow | -$53.13M | -$60.07M |
| YoY Change | -11.55% | 4109.6% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q1 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
195000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-31648000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-5122000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
16807000 | |
| CY2021Q1 | alks |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
-4177000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-71949000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1243000 | |
| CY2021Q1 | alks |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-3996000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-217000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-45146000 | |
| CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7986000 | |
| CY2021Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
122545000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
27212000 | |
| CY2021Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
86193000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
64500000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-37732000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
17492000 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2053000 | |
| CY2020Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
3070000 | |
| CY2021Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
10413000 | |
| CY2020Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
7283000 | |
| CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
362066000 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-38654000 | |
| CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
127430000 | |
| CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
131718000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
101785000 | |
| CY2020Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
|
6800000 | |
| CY2020Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
47211000 | |
| CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
93279000 | |
| CY2020Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
133372000 | |
| CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9728000 | |
| CY2020Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
283590000 | |
| CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-37370000 | |
| CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2760000 | |
| CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-658000 | |
| CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
6045000 | |
| CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-31325000 | |
| CY2021Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-171000 | |
| CY2021Q1 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
248000 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
158095000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
87000 | |
| CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-38337000 | |
| CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-38654000 | |
| CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
20608000 | |
| CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
19813000 | |
| CY2020Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
3665000 | |
| CY2020Q1 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
283000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-10370000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-67933000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-27704000 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
272961000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
203771000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
205028000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
176067000 | |
| CY2021Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
995000 | |
| CY2020Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
5242000 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2053000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
5813000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
8652000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6842000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
-13615000 | |
| CY2020Q1 | alks |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
-3926000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-51254000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-859000 | |
| CY2020Q1 | alks |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-2378000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
48000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-40272000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
19799000 | |
| CY2021Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
176000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
3000 | |
| CY2021Q1 | alks |
Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
|
6430000 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
23567000 | |
| CY2021Q1 | us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
262000 | |
| CY2020Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
711000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14945000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4924000 | |
| CY2021Q1 | alks |
Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
|
-10413000 | |
| CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
15552000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-174000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-601000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22418000 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1051155000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1085442000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
3071000 | |
| CY2020Q1 | alks |
Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
|
-7283000 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
20125000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
87000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
317000 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-38654000 | |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1063018000 | |
| CY2021Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="N1_COMPANY" style="margin-top:10pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. THE COMPANY</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alkermes plc is a fully-integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas. Alkermes has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, the Company has a research and development (“R&D”) center in Waltham, Massachusetts; an R&D and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.</p> | |
| CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires that management make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies, including those related to revenue from contracts with its customers and related allowances, impairment and amortization of intangibles and long-lived assets, share-based compensation, income taxes including the valuation allowance for deferred tax assets, valuation of investments, contingent consideration and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.</p> | |
| CY2021Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2021Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
9300000 | |
| CY2020Q4 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
19401000 | |
| CY2021Q1 | alks |
Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
|
8785000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
|
13907000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
14279000 | |
| CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
23909000 | |
| CY2020Q4 | alks |
Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
|
24805000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-1243000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
22666000 | |
| CY2021Q1 | alks |
Short Term Investment Amortized Cost
ShortTermInvestmentAmortizedCost
|
334594000 | |
| CY2021Q1 | alks |
Short Term Investment Securities Unrealized Gain Loss
ShortTermInvestmentSecuritiesUnrealizedGainLoss
|
1421000 | |
| CY2021Q1 | alks |
Short Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
ShortTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
48000 | |
| CY2021Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
335967000 | |
| CY2021Q1 | alks |
Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
|
86546000 | |
| CY2021Q1 | alks |
Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
98000 | |
| CY2021Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
86448000 | |
| CY2021Q1 | alks |
Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
|
421140000 | |
| CY2021Q1 | alks |
Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
|
1421000 | |
| CY2021Q1 | alks |
Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
146000 | |
| CY2021Q1 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
422415000 | |
| CY2020Q4 | alks |
Short Term Investment Amortized Cost
ShortTermInvestmentAmortizedCost
|
360961000 | |
| CY2020Q4 | alks |
Short Term Investment Securities Unrealized Gain Loss
ShortTermInvestmentSecuritiesUnrealizedGainLoss
|
2097000 | |
| CY2020Q4 | alks |
Short Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
ShortTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
15000 | |
| CY2020Q4 | alks |
Short Term Investment Securities Allowance For Credit Loss
ShortTermInvestmentSecuritiesAllowanceForCreditLoss
|
977000 | |
| CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
362066000 | |
| CY2020Q4 | alks |
Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
25000 | |
| CY2020Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
24780000 | |
| CY2020Q4 | alks |
Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
|
385766000 | |
| CY2020Q4 | alks |
Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
|
2097000 | |
| CY2020Q4 | alks |
Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
|
40000 | |
| CY2020Q4 | alks |
Marketable Securities Allowance For Credit Loss
MarketableSecuritiesAllowanceForCreditLoss
|
977000 | |
| CY2020Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
386846000 | |
| CY2021Q1 | us-gaap |
Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
|
0 | |
| CY2020Q1 | us-gaap |
Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
|
0 | |
| CY2021Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
86193000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
64500000 | |
| CY2020Q1 | alks |
Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
|
9000 | |
| CY2021Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
365881000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
346327000 | |
| CY2020Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
33428000 | |
| CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
|
-6429000 | |
| CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
|
18000 | |
| CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
28259000 | |
| CY2021Q1 | alks |
Milestone Payments Received
MilestonePaymentsReceived
|
1400000 | |
| CY2021Q1 | alks |
Additional Milestone Annual Payment To Be Paid
AdditionalMilestoneAnnualPaymentToBePaid
|
38600000 | |
| CY2021Q1 | alks |
Number Of Equal Annual Installments Milestone Payment
NumberOfEqualAnnualInstallmentsMilestonePayment
|
6 | |
| CY2021Q1 | alks |
Percentage Of Discount Recovery Rate
PercentageOfDiscountRecoveryRate
|
0.18 | |
| CY2020Q4 | alks |
Percentage Of Discount Recovery Rate
PercentageOfDiscountRecoveryRate
|
0.18 | |
| CY2021Q1 | us-gaap |
Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
|
27300000 | |
| CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
|
32500000 | |
| CY2021Q1 | us-gaap |
Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
|
7900000 | |
| CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
|
7800000 | |
| CY2021Q1 | us-gaap |
Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
|
19400000 | |
| CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
|
24700000 | |
| CY2021Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
|
1300000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
238884000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
239281000 | |
| CY2021Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
3488000 | |
| CY2021Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
3667000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
178768000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
179467000 | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
417652000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
418748000 | |
| CY2021Q1 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
3488000 | |
| CY2021Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
3667000 | |
| CY2021Q1 | alks |
Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level One To Level Two
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelOneToLevelTwo
|
0 | |
| CY2021Q1 | alks |
Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level Two To Level One
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelTwoToLevelOne
|
0 | |
| CY2020Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
|
6800000 | |
| CY2021Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
47788000 | |
| CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
44944000 | |
| CY2021Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
56081000 | |
| CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
53243000 | |
| CY2021Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
30309000 | |
| CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
27551000 | |
| CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
134178000 | |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
125738000 | |
| CY2021Q1 | alks |
Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
|
25400000 | |
| CY2020Q4 | alks |
Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
|
26500000 | |
| CY2021Q1 | alks |
Fifo Inventory Advance Capitalization Amount
FIFOInventoryAdvanceCapitalizationAmount
|
14000000.0 | |
| CY2020Q4 | alks |
Fifo Inventory Advance Capitalization Amount
FIFOInventoryAdvanceCapitalizationAmount
|
13800000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
712208000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
191480000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
195806000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
60143000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
60610000 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
131337000 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
706146000 | |
| CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
356143000 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
350003000 | |
| CY2021Q1 | us-gaap |
Goodwill Gross
GoodwillGross
|
92873000 | |
| CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
92873000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
582750000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
480965000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
101785000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
40000000.0 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
35000000.0 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
35000000.0 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1000000.0 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
16882000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
17001000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
17001000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
17266000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
17266000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
17536000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
17536000 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
17810000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
17810000 | |
| CY2021Q1 | alks |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
109002000 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
109311000 | |
| CY2021Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P12Y4M24D | |
| CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2400000 | |
| CY2021Q1 | alks |
Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
|
191113000 | |
| CY2020Q4 | alks |
Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
|
218877000 | |
| CY2021Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
62521000 | |
| CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
76082000 | |
| CY2021Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
339088000 | |
| CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
412171000 | |
| CY2021Q1 | alks |
Number Of Lender Holding Percentage Of Outstanding Amount
NumberOfLenderHoldingPercentageOfOutstandingAmount
|
3 | |
| CY2020Q3 | alks |
Maximum Period Before Fda Can Approve Patent Request
MaximumPeriodBeforeFDACanApprovePatentRequest
|
P30M | |
| CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
15451000 | |
| CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
19813000 | |
| CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
2700000 | |
| CY2020 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
2600000 | |
| CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
18328 | |
| CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
19245 | |
| CY2021Q1 | us-gaap |
Loss Contingency Accrual Provision
LossContingencyAccrualProvision
|
0 |
